Cargando…

Evolution of clinical features in possible DLB depending on FP-CIT SPECT result

OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core an...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Zuzana, Moreno, Emilio, Thomas, Alan, Inglis, Fraser, Tabet, Naji, Stevens, Tim, Whitfield, Tim, Aarsland, Dag, Rainer, Michael, Padovani, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027811/
https://www.ncbi.nlm.nih.gov/pubmed/27511183
http://dx.doi.org/10.1212/WNL.0000000000003076
_version_ 1782454300743565312
author Walker, Zuzana
Moreno, Emilio
Thomas, Alan
Inglis, Fraser
Tabet, Naji
Stevens, Tim
Whitfield, Tim
Aarsland, Dag
Rainer, Michael
Padovani, Alessandro
author_facet Walker, Zuzana
Moreno, Emilio
Thomas, Alan
Inglis, Fraser
Tabet, Naji
Stevens, Tim
Whitfield, Tim
Aarsland, Dag
Rainer, Michael
Padovani, Alessandro
author_sort Walker, Zuzana
collection PubMed
description OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result. METHODS: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis. RESULTS: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson’s Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result. CONCLUSIONS: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia.
format Online
Article
Text
id pubmed-5027811
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-50278112016-09-27 Evolution of clinical features in possible DLB depending on FP-CIT SPECT result Walker, Zuzana Moreno, Emilio Thomas, Alan Inglis, Fraser Tabet, Naji Stevens, Tim Whitfield, Tim Aarsland, Dag Rainer, Michael Padovani, Alessandro Neurology Article OBJECTIVE: To test the hypothesis that core and suggestive features in possible dementia with Lewy bodies (DLB) would vary in their ability to predict an abnormal dopamine transporter scan and therefore a follow-up diagnosis of probable DLB. A further objective was to assess the evolution of core and suggestive features in patients with possible DLB over time depending on the (123)I-FP-CIT SPECT scan result. METHODS: A total of 187 patients with possible DLB (dementia plus one core or one suggestive feature) were randomized to have dopamine transporter imaging or to follow-up without scan. DLB features were compared at baseline and at 6-month follow-up according to imaging results and follow-up diagnosis. RESULTS: For the whole cohort, the baseline frequency of parkinsonism was 30%, fluctuations 29%, visual hallucinations 24%, and REM sleep behavior disorder 17%. Clinician-rated presence of parkinsonism at baseline was significantly (p = 0.001) more frequent and Unified Parkinson’s Disease Rating Scale (UPDRS) score at baseline was significantly higher (p = 0.02) in patients with abnormal imaging. There was a significant increase in UPDRS score in the abnormal scan group over time (p < 0.01). There was relatively little evolution of the rest of the DLB features regardless of the imaging result. CONCLUSIONS: In patients with possible DLB, apart from UPDRS score, there was no difference in the evolution of DLB clinical features over 6 months between cases with normal and abnormal imaging. Only parkinsonism and dopamine transporter imaging helped to differentiate DLB from non-DLB dementia. Lippincott Williams & Wilkins 2016-09-06 /pmc/articles/PMC5027811/ /pubmed/27511183 http://dx.doi.org/10.1212/WNL.0000000000003076 Text en © 2016 American Academy of Neurology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Article
Walker, Zuzana
Moreno, Emilio
Thomas, Alan
Inglis, Fraser
Tabet, Naji
Stevens, Tim
Whitfield, Tim
Aarsland, Dag
Rainer, Michael
Padovani, Alessandro
Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title_full Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title_fullStr Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title_full_unstemmed Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title_short Evolution of clinical features in possible DLB depending on FP-CIT SPECT result
title_sort evolution of clinical features in possible dlb depending on fp-cit spect result
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027811/
https://www.ncbi.nlm.nih.gov/pubmed/27511183
http://dx.doi.org/10.1212/WNL.0000000000003076
work_keys_str_mv AT walkerzuzana evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT morenoemilio evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT thomasalan evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT inglisfraser evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT tabetnaji evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT stevenstim evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT whitfieldtim evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT aarslanddag evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT rainermichael evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult
AT padovanialessandro evolutionofclinicalfeaturesinpossibledlbdependingonfpcitspectresult